Media & PRESS

“Kinnevik concludes a solid second quarter with strong growth and continued margin improvements in our core companies. We also continue to selectively add exciting companies to our portfolio and in the quarter we led a funding round in Tandem Health. We are proud to partner with a Swedish company at the intersection of healthcare, SaaS and AI, as it pioneers the next generation of healthcare infrastructure in Europe.”

Kinnevik AB (publ) ("Kinnevik") will publish its financial results for the second quarter of 2025 on 8 July 2025 at 08.00 CET, with a conference call held the same day at 10.00 CET to present the results.

Kinnevik AB (publ) ("Kinnevik") today announced that as of 30 May 2025, the total number of shares in the company amounts to 281,771,701, and the total number of votes in the company amounts to 585,570,589.

Kinnevik AB (publ) ("Kinnevik") today held its Annual General Meeting (the "AGM"). The AGM resolved in accordance with all proposals of the Board and the Nomination Committee.